A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
Autoimmune Disorder Juvenile Idiopathic Arthritis
For the latest version of this information please go to www.forpatients.roche.com